Raymond James & Associates »

Predictive Oncology shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Predictive Oncology (POAI) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Predictive Oncology

Tip: Access up to 7 years of quarterly data

All positions including Predictive Oncology held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Predictive Oncology by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $308k 121k 2.55
2023-12-31 $397k 121k 3.29
2023-09-30 $378k 118k 3.20